Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
| Current Price | ₹17,968.00 |
|---|---|
| Market Cap | ₹21,810 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 59.9 |
| Return on Equity | 21.42% |
| 52-Week Range | ₹11,500.00 – ₹19,747.00 |
| Beta (1Y) | 1.28 |
| Dividend Yield | 0.20% |
1. Manufacture and Sale of Active Pharmaceutical Ingredients and Allied Services-100%
Neuland Laboratories Ltd. is trading at ₹17,968.00, with a market capitalisation of ₹21,810 Cr.
Neuland Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Neuland Laboratories Ltd. has a P/E of 59.9 and a return on equity of 21.42%.